In this section, you can find the other relevant financial and corporate information filed with the Spanish National Securities and Exchange Commission (CNMV) by MAPFRE, in line with the current Spanish legislation.
The company guarantees that these documents are in all respects identical to those filed with the Spanish National Securities and Exchange Commission, either by the company itself or by third parties, whenever, regarding the latter, they were released by MAPFRE. These documents can also be found on the CNMV website.
For documents corresponding to years prior to 2020, please see the Archive of relevant facts on our website.
Financial year 2024
(04.2024) 3M 2024 activity report
(04.2024) Presentation for 3M 2024 activity report
(04.2024) Information regarding the 2023 final dividend
(04.2024) 3M 2024 Activity update webcast announcement
(03.2024) AGM – Approval of proposals
(03.2024) AGM – Chairman and CEO’s report
(03.2024) Fitch raises MAPFRE’s Tier 3 subordinated debt rating
(02.2024) Annual Report on Remuneration to Directors 2023
(02.2024) Corporate Governance Annual Report 2023
(02.2024) Appointments and resignations agreed by the Board of Directors
(02.2024) Resolutions proposed to the AGM
(02.2024) Calling of the Annual General Meeting
(02.2024) Second half financial information 2023
(02.2024) Press presentation 2023 results
(02.2024) Analyst presentation 12M 2023
Financial year 2023
(12.2023) Proposals for external auditor reelection and appointment
(11.2023) Information on the Solvency ratio
(11.2023) Information regarding the 2023 interim dividend
(10.2023) Third quarter 2023 activity report
(10.2023) Presentation for the third quarter 2023 activity report
(10.2023) Information regarding the 2023 interim dividend
(10.2023) Appointments and resignations agreed by the Board of Directors
(10.2023) 9M 2023 Activity update webcast announcement
(09.2023) Information on the Solvency ratio
(07.2023) Press release 6M 2023
(07.2023) Presentation on the first half 2023 activity update
(07.2023) Appointments agreed by the Board of Directors
(07.2023) Acquisition agreement for the Mexican insurance company Insignia Life
(07.2023) 6M 2023 Activity update webcast announcement
(05.2023) Information on the Solvency ratio
(05.2023) Information regarding the 2022 final dividend
(04.2023) Information regarding the 2022 final dividend
(04.2023) Press release 3M 2023
(04.2023) 3M 2023 Activity update webcast announcement
(03.2023) Information on the Solvency ratio
(03.2023) AGM – Approval of proposals
(03.2023) AGM – Chairman and CEO’s report
(03.2023) AGM –Appointments agreed by the Board of Directors
(02.2023) Press release 4Q 2022 results
(02.2023) Results presentation 4Q 2022
(02.2023) Financial information 4Q 2022
(02.2023) Second half financial information 2022
(02.2023) Press presentation 2022 results
(02.2023) Calling of the Annual General Meeting
(02.2023) Resolutions proposed to the AGM
(02.2023) Corporate Governance Annual Report 2022
(02.2023) Annual Report on Remuneration to Directors 2022
(01.2023) 4Q 2022 Results presentation announcement
(01.2023) The Company announces the stepping down of a Director
(01.2023) Advance information regarding premiums
Financial year 2022
(11.2022) Information on the Solvency ratio
(11.2022) Information regarding the 2022 interim dividend
(10.2022) Press release third quarter 2022 results
(10.2022) Results presentation 3Q 2022
(10.2022) Financial information 3Q 2022
(10.2022) Information regarding the 2022 interim dividend
(10.2022) Appointments agreed by the Board of Directors
(10.2022) 9M 2022 Results webcast announcement
(10.2022) The Company announces the stepping down of a Director
(10.2022) Advance information regarding premiums
(08.2022) Sale of holding in ABDA and ABDA ASSISTANCE
(08.2022) Information on the Solvency ratio
(07.2022) Press release 6M 2022 results
(07.2022) Results presentation 6M 2022
(07.2022) Financial information 6M 2022
(07.2022) Standard & Poor’s maintains MAPFRE’s rating
(07.2022) 6M 2022 Results webcast announcement
(07.2022) Advance information regarding premiums
(07.2022) Fitch reaffirms MAPFRE’s rating
(05.2022) Information on the Solvency ratio
(05.2022) Regulations of the Board of Directors
(05.2022) Regulations of the Annual General Meeting
(05.2022) Information regarding the 2021 final dividend
(04.2022) Press release 1Q 2022 results
(04.2022) Results presentation 1Q 2022
(04.2022) Financial information 1Q 2022
(04.2022) Market consistent embedded value 2021
(04.2022) Announcement of final dividend
(04.2022) 3M 2022 Results webcast announcement
(04.2022) Advance information regarding premiums
(03.2022) AGM – Approval of proposals
(03.2022) AGM – Chairman and CEO’s report
(03.2022) Information on the Solvency ratio
(03.2022) Sale of holding in ABDA and ABDA ASSISTANCE
(02.2022) The Company informs of the passing of a board member
(02.2022) Press release 4Q 2021 results
(02.2022) Results presentation 4Q 2021
(02.2022) Financial information 4Q 2021
(02.2022) Second half financial information 2021
(02.2022) Press presentation 2021 results
(02.2022) Calling of the Annual General Meeting
(02.2022) Resolutions proposed to the AGM
(02.2022) Corporate Governance Annual Report 2021
(02.2022) Annual Report on Remuneration to Directors 2021
Financial year 2021
(12.2021) The Company announces the change of category of a director
(12.2021) Information on the Solvency ratio
(10.2021) Information regarding the agreement with Santalucía
(10.2021) Appointments agreed by the Board of Directors
(10.2021) Information regarding the 2021 interim dividend
(10.2021) Financial information 3Q 2021
(10.2021) Results presentation 3Q 2021
(10.2021) Press release third quarter 2021 results
(10.2021) Third quarter 2021 results webcast announcement
(10.2021) Advance information regarding premiums
(09.2021) Increase in shareholding in MAPFRE PERU VIDA
(09.2021) Information on the Solvency ratio
(07.2021) Fitch reaffirms MAPFRE’s rating
(07.2021) Financial information 2Q 2021
(07.2021) Results presentation 2Q 2021
(07.2021) Press Release first half 2021 results
(07.2021) Standard & Poor’s affirms MAPFRE’s rating
(07.2021) Increase in shareholding in MAPFRE PERU VIDA
(07.2021) First half 2021 results webcast announcement
(07.2021) Advance information regarding premiums
(06.2021) Information on the Solvency ratio
(04.2021) Announcement of 2020 final dividend
(04.2021) Market consistent embedded value 2020
(04.2021) Financial information 1Q 2021
(04.2021) Results presentation 1Q 2021
(04.2021) Press Release first quarter 2021 results
(04.2021) First quarter 2021 results webcast announcement
(03.2021) Management Insights Day 2021 Presentation
(03.2021) AGM – Approval of proposals
(03.2021) AGM – Chairman and CEO’s report
(03.2021) Modifications to the Regulations of the Board of Directors 2020
(02.2021) Press release 4Q 2020 results
(02.2021) Results presentation 4Q 2020
(02.2021) Financial information 4Q 2020
(02.2021) Second half financial information 2020
(02.2021) Press presentation 2020 results
(02.2021) Calling of the Annual General Meeting
(02.2021) Resolutions proposed to the AGM
(02.2021) Corporate Governance Annual Report 2020
Financial year 2020
(12.2020) Details of interim dividend 2020
(12.2020) Information on the Solvency ratio
(10.2020) Press release 3Q 2020 results
(10.2020) Results presentation 3Q 2020
(10.2020) Financial information 3Q 2020
(10.2020) Information regarding the 2020 interim dividend
(10.2020) 3Q 2020 Results webcast announcement
(10.2020) Standard & Poor’s reaffirms MAPFRE’s rating
(09.2020) Fitch reaffirms MAPFRE’s rating
(09.2020) Appointments agreed by the Board of Directors
(07.2020) Press release first half 2020 results
(07.2020) Results presentation 2Q 2020
(07.2020) Financial information 2Q 2020
(07.2020) Market consistent embedded value 2019
(07.2020) 2Q 2020 Results webcast announcement
(06.2020) Information on final dividend
(06.2020) Information on the Solvency ratio
(05.2020) Financial report 1Q 2020
(05.2020) Information regarding first quarter 2020 results
(05.2020) Preliminary results 1Q 2020
(05.2020) Preliminary results 1Q 2020 webcast announcement
(04.2020) Announcement of final dividend
(04.2020) Fitch reaffirms MAPFRE’s rating
(03.2020) AGM – Approval of proposals
(03.2020) AGM – Chairman and CEO’s report
(02.2020) Annual Report on Remuneration to Directors 2019
(02.2020) Corporate Governance Annual Report 2019
(02.2020) Press release results 2019
(02.2020) Second half financial information 2019
(02.2020) Results presentation 2019
(02.2020) Financial report 2019
(02.2020) Press presentation 2019 results
(02.2020) Appointment agreed by the Board of Directors
(02.2020) Calling of the Annual General Meeting